Determinants of coronary artery disease in liver transplant candidates

Experimental and Clinical Transplantation

Volumn 8, Issue 2, 2010, Pages

  Aydinalp, Alp ^a   Atar, Ilyas ^a   Bal, Ugur ^a   Aktas, Ayse ^a   Ertan, Cagtay ^a   Atar, Asli ^a   Yildirir, Aylin ^a   Ozin, Bulent ^a   Muderrisoglu, Haldun ^a   Haberal, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Liver disease; Perioperative risk; Transplantation

Indexed keywords

ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD EXAMINATION; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC VALUE; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART SCINTISCANNING; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; RETROSPECTIVE STUDY; SEX RATIO; STABLE ANGINA PECTORIS; SYMPTOMATOLOGY; TREADMILL EXERCISE; VALVULAR HEART DISEASE;

EID: 77954126646     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Carey WD, Dumot JA, Pimentel RR, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation. 1995;59(6):859-864.
2. Donovan CL, Marcovitz PA, Punch JD, et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation. 1996;61(8):1180-1188.
3. Plotkin JS, Benitez RM, Kuo PC, et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg. 1998;4(4):253-257.
4. Plotkin JS, Johnson LB, Rustgi V, Kuo PC. Coronary artery disease and liver transplantation: the state of the art. Liver Transpl. 2000;6:53-56.
5. Rabkin JM, de La Melena V, Orloff SL, Corless CL, Rosen HR, Olyaei AJ. Late mortality after orthotopic liver transplantation. Am J Surg. 2001;181:475-479.
6. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg. 1996;2:426-430.
7. Keeffe BG, Valantine H, Keeffe EB. Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl. 2001;7:755-761.
8. Dec GW, Kondo N, Farrell ML, Dienstag J, Cosimi AB, Semigran MJ. Cardiovascular complications following liver transplantation. Clin Transplant. 1995;9:463-471.
9. Asfar S, Metrakos P, Fryer J, et al. An analysis of late deaths after liver transplantation. Transplantation.1996;61:1377-1381.
10. Pruthi J, Medkiff KA, Esrason KT, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl. 2001;7:811-815.
11. Romero M, Parera A, Salcedo M, et al. Cardiovascular risk factors and late cardiovascular disease in liver transplantation. Transplant Proc. 1999;31:2364-2365.
12. Tiukinhoy-Laing SD, Rossi JS, Bayram M, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol. 2006;98:178-181.
13. United Network for Organ Sharing Organ Procurement: Available at The U.S. Transplant Network/Scientific Registry of Transplant Recipients 2006 Annual report: Transplant data. Available at: http://www.ustransplant.org/annual_reports/current/survival_rates.htm.
14. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006;152:983-990.
15. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005;173:627-634.
16. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men Ischemia Research Group. N Engl J Med. 1990;323:1781-1788.
17. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002;39:542-553.
18. Zoghbi GJ, Patel AD, Ershadi RE, Heo J, Bynon JS, Iskandrian AE. Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation. Am J Cardiol. 2003;92:1066-1071.